20 years of benefit for patients with Asthma in the UK¹

Offering the flexibility of three doses, Seretide (salmeterol/fluticasone propionate) allows patients to step up and down as needed; providing continuity of care and an individual approach to managing asthma control¹

Watch the video below to find out how Seretide could help support your patients who have asthma.

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/UK/seretide-patient-success-story-video-asthma-pm-gb-fps-vid-200001.mp4

References:

Seretide is a registered trademark of the GlaxoSmithKline group of companies

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

B.B. Sep 2020. PM-GB-FPS-WCNT-200006